AVEO Pharmaceuticals Company Profile (NASDAQ:AVEO)

About AVEO Pharmaceuticals

AVEO Pharmaceuticals logoAVEO Pharmaceuticals, Inc. is a biopharmaceutical company. The Company's platform delivers insights into cancer and related disease. The Company's product candidates include Tivozanib, Ficlatuzumab, AV-203 and AV-380. Tivozanib is a selective long half-life vascular endothelial growth factor tyrosine kinase inhibitor (VEGF TKI) that inhibits over three VEGF receptors. Tivozanib is designed to optimize VEGF blockade while minimizing off-target toxicities. Ficlatuzumab is a Hepatocyte Growth Factor (HGF) inhibitory antibody. AV-203 is an anti-ErbB3 monoclonal antibody with ErbB3 affinity. Its preclinical studies suggest that neuregulin1 (NRG1) levels predict AV-203 antitumor activity in preclinical models. AV-380 is a humanized Immunoglobulin G 1 (IgG1) inhibitory monoclonal antibody. AV-380 targets growth differentiating factor 15 (GDF15).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: AVEO
  • CUSIP: 05358810
Key Metrics:
  • Previous Close: $0.79
  • 50 Day Moving Average: $0.65
  • 200 Day Moving Average: $0.74
  • 52-Week Range: $0.54 - $1.23
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.81
  • P/E Growth: 0.00
  • Market Cap: $59.17M
  • Outstanding Shares: 75,862,000
  • Beta: 0.97
Profitability:
  • Net Margins: -465.54%
  • Return on Equity: -286.18%
  • Return on Assets: -74.75%
Debt:
  • Debt-to-Equity Ratio: 3.71%
  • Current Ratio: 5.00%
  • Quick Ratio: 5.00%
Additional Links:
Companies Related to AVEO Pharmaceuticals:

Analyst Ratings

Consensus Ratings for AVEO Pharmaceuticals (NASDAQ:AVEO) (?)
Ratings Breakdown: 2 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $2.35 (201.28% upside)

Analysts' Ratings History for AVEO Pharmaceuticals (NASDAQ:AVEO)
Show:
DateFirmActionRatingPrice TargetDetails
9/13/2016FBR & CoReiterated RatingBuyView Rating Details
6/16/2016Piper Jaffray CompaniesReiterated RatingBuyView Rating Details
3/9/2015Royal Bank Of CanadaUpgradeUnderperform -> Sector Perform$2.00 -> $3.00View Rating Details
(Data available from 2/20/2015 forward)

Earnings

Earnings History for AVEO Pharmaceuticals (NASDAQ:AVEO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/13/2017        
5/10/2016Q1($0.12)($0.13)ViewN/AView Earnings Details
3/15/2016Q415($0.04)($0.11)$3.60 millionViewN/AView Earnings Details
11/9/2015Q315($0.09)$0.14ViewN/AView Earnings Details
8/10/2015Q2($0.16)($0.10)ViewListenView Earnings Details
5/7/2015Q115($0.25)($0.21)ViewN/AView Earnings Details
3/6/2015Q314($0.28)($0.27)ViewListenView Earnings Details
11/5/2014($0.23)($0.28)ViewN/AView Earnings Details
8/11/2014Q214($0.44)($0.35)$1.75 millionViewN/AView Earnings Details
5/7/2014($0.40)($0.12)ViewN/AView Earnings Details
3/13/2014Q413($0.33)($0.32)$0.14 million$0.32 millionViewListenView Earnings Details
11/4/2013Q313($0.47)($0.47)$0.23 million$0.32 millionViewN/AView Earnings Details
8/1/2013Q213($0.56)($0.62)$4.30 million$0.32 millionViewN/AView Earnings Details
4/29/2013Q1 2013($0.72)($0.69)$2.52 million$0.32 millionViewListenView Earnings Details
2/13/2013Q4 2012($0.77)($0.49)$14.49 million$15.53 millionViewN/AView Earnings Details
10/30/2012Q312($0.87)($0.69)$6.57 million$1.02 millionViewN/AView Earnings Details
8/2/2012($0.82)($0.68)ViewN/AView Earnings Details
5/3/2012($0.78)($0.77)ViewN/AView Earnings Details
2/14/2012($0.64)($0.58)ViewN/AView Earnings Details
11/2/2011($0.46)($0.55)ViewN/AView Earnings Details
7/28/2011($0.80)($0.16)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for AVEO Pharmaceuticals (NASDAQ:AVEO)
Current Year EPS Consensus Estimate: $-0.43 EPS
Next Year EPS Consensus Estimate: $-0.43 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.13)($0.13)($0.13)
Q2 20161($0.15)($0.15)($0.15)
Q3 20161($0.18)($0.18)($0.18)
Q4 20161($0.09)($0.09)($0.09)
Q1 20171($0.10)($0.10)($0.10)
Q2 20171($0.06)($0.06)($0.06)
Q3 20171($0.12)($0.12)($0.12)
Q4 20171($0.11)($0.11)($0.11)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for AVEO Pharmaceuticals (NASDAQ:AVEO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for AVEO Pharmaceuticals (NASDAQ:AVEO)
Insider Ownership Percentage: 5.10%
Institutional Ownership Percentage: 37.94%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/16/2015Matthew D DallasVPSell3,075$0.82$2,521.50View SEC Filing  
1/7/2015Michael P BaileyCEOSell4,484$0.80$3,587.20View SEC Filing  
1/30/2014Joseph VittiglioSVPSell5,430$1.64$8,905.20View SEC Filing  
3/14/2013David Brannon JohnstonCFOSell1,061$7.34$7,787.74View SEC Filing  
3/7/2013Henri A TermeerDirectorBuy55,499$6.73$373,508.27View SEC Filing  
12/13/2012Ngoc Tuan HaCEOBuy75,000$6.65$498,750.00View SEC Filing  
12/13/2012Robert C YoungDirectorBuy2,371$6.78$16,075.38View SEC Filing  
12/3/2012Robert C YoungDirectorBuy1,250$6.41$8,012.50View SEC Filing  
9/13/2012David Brannon JohnstonCFOSell1,386$10.60$14,691.60View SEC Filing  
8/8/2012Robert C YoungDirectorBuy1,000$8.63$8,630.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for AVEO Pharmaceuticals (NASDAQ:AVEO)
DateHeadline
News IconAVEO Pharmaceuticals, Inc. (AVEO): Essential Chart Information ... - NY Stock News (NASDAQ:AVEO)
nystocknews.com - February 18 at 9:49 AM
News IconGrowth Advanced Renal Cell Carcinoma Therapeutics Market :2017 – 2025 (NASDAQ:AVEO)
www.ssuchronicle.com - February 16 at 8:49 PM
News IconGrowth Advanced Renal Cell Carcinoma Therapeutics Market :2017 – 2025 (NASDAQ:AVEO)
www.ssuchronicle.com - February 16 at 8:49 PM
News IconEquity Watch for AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) - Baxter Review (NASDAQ:AVEO)
baxternewsreview.com - February 16 at 8:36 AM
istreetwire.com logoStocks In Action: Marinus Pharmaceuticals, Inc. (MRNS), AVEO Pharmaceuticals, Inc. (AVEO), Patterson Companies ... - iStreetWire (NASDAQ:AVEO)
istreetwire.com - February 16 at 8:36 AM
News IconTrending Stocks Analysis Report: Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS), AVEO Pharmaceuticals, Inc ... - The Newburgh Press (NASDAQ:AVEO)
newburghpress.com - February 16 at 8:36 AM
News IconTargeted Cancer Therapies Market Estimated to Grow Strongly by 2017 – 2025 (NASDAQ:AVEO)
www.medgadget.com - February 15 at 2:30 AM
seekingalpha.com logoAVEO Pharmaceuticals (AVEO) Presents at 19th Annual BIO CEO & Investor Conference (NASDAQ:AVEO)
seekingalpha.com - February 14 at 4:25 PM
News IconTechnical Levels in Review on Shares of AVEO Pharmaceuticals Inc ... - Davidson Register (NASDAQ:AVEO)
davidsonregister.com - February 11 at 2:19 AM
News IconTechnical Levels in Review on Shares of AVEO Pharmaceuticals Inc. (AVEO) - Davidson Register (NASDAQ:AVEO)
davidsonregister.com - February 11 at 2:19 AM
reuters.com logoBRIEF-Aveo reports clinical and regulatory updates for tivozanib (NASDAQ:AVEO)
www.reuters.com - February 9 at 8:53 PM
finance.yahoo.com logoAVEO Announces Clinical and Regulatory Updates for Tivozanib (NASDAQ:AVEO)
finance.yahoo.com - February 9 at 8:53 PM
finance.yahoo.com logo4:15 pm AVEO Oncology reports Tivozanib pivotal TIVO-3 trial enrollment is proceeding 'substantially ahead of schedule'; not revising anticipated topline data time (NASDAQ:AVEO)
finance.yahoo.com - February 9 at 8:53 PM
News IconTrading Radar: Zooming in on Shares of AVEO Pharmaceuticals Inc. (AVEO) - Piedmont Register (NASDAQ:AVEO)
piedmontregister.com - February 8 at 3:36 PM
finance.yahoo.com logoAVEO to Present at the 19th Annual BIO CEO & Investor Conference (NASDAQ:AVEO)
finance.yahoo.com - February 6 at 3:45 PM
News IconChart Level Analysis on Shares of AVEO Pharmaceuticals Inc. (AVEO) - Sherwood Daily (NASDAQ:AVEO)
sherwooddaily.com - February 3 at 3:51 PM
News IconSignal Watch: Checking the Numbers for AVEO Pharmaceuticals Inc. (AVEO) - Sherwood Daily (NASDAQ:AVEO)
sherwooddaily.com - February 3 at 1:51 AM
finance.yahoo.com logoPipeline of Non-Small Cell Lung Cancer Market Review Research for H2 2016 - Yahoo Finance (NASDAQ:AVEO)
finance.yahoo.com - February 2 at 3:46 PM
News IconNewsworthy Wonder Stock: Penny Stock Investors Looking at AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) - Nelson Research (NASDAQ:AVEO)
nelsonobserver.com - February 1 at 8:53 PM
News IconStock Dragging Lower Heading Into The Open: AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) - Aiken Advocate (NASDAQ:AVEO)
aikenadvocate.com - February 1 at 8:53 PM
News IconAverage Directional Index in Review for AVEO Pharmaceuticals Inc. (AVEO) - Sherwood Daily (NASDAQ:AVEO)
sherwooddaily.com - February 1 at 3:53 PM
News IconOn the Hunt For the Next Wonder Stock: Penny Stock AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) - Nelson Research (NASDAQ:AVEO)
nelsonobserver.com - February 1 at 3:53 PM
News IconEquity Focus: Indicator Check on Shares of AVEO Pharmaceuticals Inc. (AVEO) - Sherwood Daily (NASDAQ:AVEO)
sherwooddaily.com - January 31 at 2:49 AM
News IconDelving into Shares of AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) - Prospect Journal (NASDAQ:AVEO)
prospectjournal.com - January 31 at 2:49 AM
News IconIs This Stock Capable of a Bull Run: AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) - Nelson Research (NASDAQ:AVEO)
nelsonobserver.com - January 31 at 2:49 AM
News IconAre the Technicals Adding up for AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) - Prospect Journal (NASDAQ:AVEO)
prospectjournal.com - January 27 at 9:57 PM
News IconMarket Rover: Looking at Levels on Shares of AVEO Pharmaceuticals Inc. (AVEO) - Sherwood Daily (NASDAQ:AVEO)
sherwooddaily.com - January 26 at 4:09 PM
News IconTrading Corner: Eye on Technical Levels for AVEO Pharmaceuticals Inc. (AVEO) - Sherwood Daily (NASDAQ:AVEO)
sherwooddaily.com - January 25 at 3:51 PM
News IconCan This Stock Pick Up Any Momentum: AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) - Prospect Journal (NASDAQ:AVEO)
prospectjournal.com - January 25 at 3:51 PM
News IconBroker Changes For AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) - NewsDen (NASDAQ:AVEO)
newsden.net - January 24 at 4:12 PM
News IconTrading Sheet: Tracking Technicals for AVEO Pharmaceuticals Inc. (AVEO) - Sherwood Daily (NASDAQ:AVEO)
sherwooddaily.com - January 24 at 4:12 PM
News IconInvestor Sphere: Keeping an Eye on Levels for AVEO Pharmaceuticals Inc. (AVEO) - Sherwood Daily (NASDAQ:AVEO)
sherwooddaily.com - January 23 at 3:48 PM
News IconKeen Investors Taking a Look at AVEO Pharmaceuticals, Inc ... - Prospect Journal (NASDAQ:AVEO)
prospectjournal.com - January 23 at 3:48 PM
News IconTrump Sworn In as S&P Declined, How Did this Stock Perform This Week: AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) - Aiken Advocate (NASDAQ:AVEO)
aikenadvocate.com - January 21 at 3:41 PM
News IconCheap Stock Alert & Update on AVEO Pharmaceuticals, Inc ... - Prospect Journal (NASDAQ:AVEO)
prospectjournal.com - January 21 at 2:47 AM
News IconMonitoring Relative Strength Index Values for AVEO Pharmaceuticals Inc. (AVEO) - Sherwood Daily (NASDAQ:AVEO)
sherwooddaily.com - January 20 at 4:44 PM
4-traders.com logoGoldberg Law PC Announces a Class Action Lawsuit Against Ophthotech Corporation and Advises Investors with Losses to Contact the Firm (NASDAQ:AVEO)
www.4-traders.com - January 19 at 9:51 PM
News IconTrading Scope: Indicator Review for AVEO Pharmaceuticals Inc. (AVEO) - Sherwood Daily (NASDAQ:AVEO)
sherwooddaily.com - January 19 at 4:49 PM
News IconAre Institutions Trimming Down Their Positions In AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) - Wall Street Beacon (NASDAQ:AVEO)
wsbeacon.com - January 19 at 4:49 PM
News IconWatching the Charts on Shares of AVEO Pharmaceuticals Inc. (AVEO) - Sherwood Daily (NASDAQ:AVEO)
sherwooddaily.com - January 17 at 9:28 PM
News IconNewest Short Interest Filing: Aveo Pharmaceuticals Incorporated (NASDAQ:AVEO) Shorted Shares Increased By 8.85% - Baxley Report (NASDAQ:AVEO)
baxleyreport.com - January 17 at 9:28 PM
News IconZeroing in on Company Shares of AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) - Prospect Journal (NASDAQ:AVEO)
prospectjournal.com - January 17 at 9:28 PM
4-traders.com logoLundin Law PC Announces Securities Class Action Lawsuit against Ophthotech Corporation and Encourages Investors with Losses to Contact the Firm (NASDAQ:AVEO)
www.4-traders.com - January 17 at 4:26 PM
4-traders.com logoOPHTHOTECH : Costs Associated with Exit or Disposal Activities (form 8-K/A) (NASDAQ:AVEO)
www.4-traders.com - January 17 at 9:48 AM
News IconBargain Hunters Should Take a Look at AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) - Prospect Journal (NASDAQ:AVEO)
prospectjournal.com - January 16 at 8:45 PM
biz.yahoo.com logoAVEO PHARMACEUTICALS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or St (NASDAQ:AVEO)
biz.yahoo.com - January 12 at 8:52 PM
News IconIs There a Spark Ahead for AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) - Prospect Journal (NASDAQ:AVEO)
prospectjournal.com - January 12 at 3:50 PM
News IconStock Edging Lower Out Of The Gate: AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) - Wall Street Beacon (NASDAQ:AVEO)
wsbeacon.com - January 12 at 3:50 PM
News IconInvestors Swarm in on AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) - Prospect Journal (NASDAQ:AVEO)
prospectjournal.com - January 10 at 3:49 PM
marketexclusive.com logoAVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) Files An 8-K Termination of a Material Definitive Agreement - Market Exclusive (NASDAQ:AVEO)
marketexclusive.com - January 9 at 4:51 PM

Social

What is AVEO Pharmaceuticals' stock symbol?

AVEO Pharmaceuticals trades on the NASDAQ under the ticker symbol "AVEO."

Where is AVEO Pharmaceuticals' stock going? Where will AVEO Pharmaceuticals' stock price be in 2017?

2 brokerages have issued 12-month target prices for AVEO Pharmaceuticals' stock. Their predictions range from $1.70 to $3.00. On average, they anticipate AVEO Pharmaceuticals' share price to reach $2.35 in the next year.

When will AVEO Pharmaceuticals announce their earnings?

AVEO Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Monday, March, 13th 2017.

Who owns AVEO Pharmaceuticals stock?

AVEO Pharmaceuticals' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Perceptive Advisors LLC (4.10%), Renaissance Technologies LLC (3.62%), New Leaf Venture Partners L.L.C. (3.41%) and Sarissa Capital Management LP (2.24%).

Who bought AVEO Pharmaceuticals stock? Who is buying AVEO Pharmaceuticals stock?

AVEO Pharmaceuticals' stock was acquired by a variety of institutional investors in the last quarter, including Perceptive Advisors LLC, New Leaf Venture Partners L.L.C., Sarissa Capital Management LP and Renaissance Technologies LLC.

How do I buy AVEO Pharmaceuticals stock?

Shares of AVEO Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of AVEO Pharmaceuticals stock cost?

One share of AVEO Pharmaceuticals stock can currently be purchased for approximately $0.78.

AVEO Pharmaceuticals (NASDAQ:AVEO) Chart for Monday, February, 20, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for AVEO Pharmaceuticals (NASDAQ:AVEO)

Earnings History Chart

Earnings by Quarter for AVEO Pharmaceuticals (NASDAQ:AVEO)

Dividend History Chart

Dividend Payments by Quarter for AVEO Pharmaceuticals (NASDAQ:AVEO)

Last Updated on 2/20/2017 by MarketBeat.com Staff